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Background: High-throughput studies provide a wide spectrum of genes for use as predictive markers during
testicular sperm extraction (TESE) in combination with ICSI. In this work, we used the specimens from testicular
biopsies of men with non-obstructive azoospermia who underwent TESE to investigate the expression of
spermatogenesis-related genes MND1, SPATA22, GAPDHS and ACR.
Methods: Testicular biopsy specimens were subdivided into three groups: hypospermatogenesis (HS); maturation
arrest (MA); and Sertoli cell-only syndrome (SCO). The levels of expression of the spermatogenesis-related genes
MND1, SPATA22, GAPDHS and ACR in the testes were compared among these three groups using the reverse
transcription polymerase chain reaction (RT-PCR) technique.
Results: Analysis of the expression of spermatogenic genes in human testes with abnormal spermatogenesis
showed different expression patterns in patients from different groups. Fertilization rate for studied set of patients
was 66% and pregnancy rate 29%. For HS group fertilization rate was 72% and pregnancy rate 32%, while for MA
group fertilization and pregnancy rates were 54% and 26%, respectively. Fertilization rates in relation to the studied
genes were uniformly around 70%, pregnancy rates for ACR and GAPDHS genes were surprisingly low at 6% and
8% correspondingly.
Conclusions: Analysis of the expression of genes involved in spermatogenesis can be a fast additional test for the
level of spermatogenesis in testicular samples.
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Testicular tissue is composed of many cell types serving
as spatio-temporal environment for the male germ cell
development. It is the only place in the male organism
where meiosis occurs. After meiotic division, gene ex-
pression continues in haploid cells until chromatin con-
densation to produce proteins necessary for the final
stages of spermatogenesis [1]. Germ cells also employ
mechanisms for mRNA storage and delayed translation
after chromatin has already been packaged. The final
products of spermiogenesis are highly differentiated
sperm cells, which are transcriptionally inactive. The rate* Correspondence: jana.peknicova@img.cas.cz
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reproduction in any medium, provided the orof cell proliferation in testicular tissue is higher than in
other tissues due to continuous sperm production. All
these facts make gene expression analysis of testicular
tissues extremely important.
Changes in the complex process of spermatogenesis
caused by genetic background or environmental factors
can lead to male infertility. Infertile men with no sperm
cells in the ejaculate can father a child with the help of
assisted reproduction techniques using testicular sperm.
Intracytoplasmic sperm injection (ICSI) can be success-
ful in men with non-obstructive azoospermia, but it can-
not help patients with Sertoli cell-only (SCO) syndrome.
Genome-wide expression studies of large groups of pa-
tients were performed to analyse the general changes in
global gene expression of patients with infertility pheno-
types [2-5]. This led to the identification of gene clustersLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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atogenesis defects [4]. High-throughput studies provide
a wide spectrum of genes for use as markers in the com-
bination of testicular sperm extraction (TESE) with ICSI.
Forty-seven genes exhibiting differential testicular gene
expression associated with male infertility were detected
in mice and 19 in humans [6]. They included genes in-
volved in DNA repair, glutathione metabolism, proteoly-
sis, spermatogenesis and stress response. These findings
enabled the identification of markers for specific stages
of spermatogenesis and the presence of somatic cells,
thus improving infertility diagnostics.
In this work, we used the specimens from testicu-
lar biopsies of infertile men who underwent TESE
for the ICSI procedure and investigated the expres-
sion of spermatogenesis-related genes. The GAPDH
gene is expressed in somatic testicular cells and sperm-
atogonia. Two genes, MND1/GAJ and SPATA22, are
expressed prior to meiotic division and their corre-
sponding proteins are involved in meiotic progression
during spermatogenesis. GAPDHS and ACR genes
reach the highest expression levels in haploid sperma-
tids and are important for the sperm function.
Methods
Patients
Testicular tissue samples were collected from patients
treated for infertility in ISCARE I.V.F. a.s. A total of 47
biopsy samples were obtained from azoospermic men
aged 27–63 years. All patients enrolled in the study
underwent testicular biopsies within their treatment and
gave their written informed consent with donating the
used material for the purposes of this research project.
The study was approved by the institutional review
board at the Institute of Biotechnology.
TESE procedure, sperm extraction and ICSI
Testicular sperm extraction (TESE) was performed as
previously described [7]. Briefly, small pieces of testicular
tissue were placed in a Petri dish in Flushing medium
(Medicult, Copenhagen, Denmark) and cupped up using
two sterile needles. The fragmented tissue was assessed
for the presence of motile spermatozoa under the phase
contrast microscope. The suspension of cells was cul-
tivated for 24–48 hours before injection or freezing
procedure. Prior to the sperm retrieval procedure, a
small piece of testicular tissue was taken for histo-
logical examination.
TESE samples were divided into three groups: hypo-
spermatogenesis (HS), maturation arrest (MA), and
Sertoli cells only syndrome (SCO), with a histopathology
score counting according to Holstein et al. [8]. The cor-
responding grades were 6–8 for HS, grades 3–5 for MA
and grade 2 for the SCO group.ICSI procedures were carried out according to Silber
et al. [9]. The sperm cells were incubated in droplets of
5 μl of Flushing medium (Medicult) with 30% of human
serum for 2 hours followed by injection into the oocyte.
The fertilization rate was assessed approximately 18 h
after the injection by the presence of two pronuclei and
second polar body and was quantified as a percentage of
fertilized mature oocytes. Clinical pregnancy was con-
firmed by observing the gestational sac or detecting
foetal heart beats.
RNA purification
RNA purification was performed with the same piece of
testicular tissue that was used for the sperm extraction
and subsequently cryopreserved. Testicular biopsies with
the residual medium were thawed directly in RNAlater
RNA Stabilization Reagent (Qiagen, Chatsworth CA)
and samples were homogenized with the Precellys 24 tis-
sue homogenizer (Bertin Technologies, France). Total
RNA was purified from the tissue samples using the
RNeasy lipid tissue mini kit (Qiagen, Chatsworth CA)
according to the manufacturer’s instructions and stored
at −70°C. The concentration and purity of the purified
RNA was determined by UV spectrophotometer Helios
α (Thermo Electron Corporation, Marietta, USA) and
confirmed by agarose gel electrophoresis. Human total
testicle RNA, 1 mg/ml (Ambion®, Life Technologies™,
Carlsbad CA), was used as a positive control.
RT-qPCR
Reverse transcription and subsequent RT-qPCR was
performed as previously described [10]. Briefly, prior to
reverse transcription, purified RNA was treated with
RNAse-free DNAse 1 (Fermentas, Burlington, Canada)
for 40 min. Template cDNA was synthesized from 1 μg
of total testicular RNA using SuperScript® III Reverse
Transcriptase (Invitrogen, Life Technologies, Carlsbad
CA) or RevertAid™ Reverse Transcriptase (Fermentas,
Burlington, Canada) with combination of random hexamer
and poly(dT) primers (1:1) in a Touchgene Gradient Ther-
mal Cycler (Techne, Burlington, USA). The qPCR condi-
tions were: initial denaturation for 15 min, followed by
40 cycles of denaturation at 94°C for 20 sec, annealing at
60°C for 30 sec, and extension at 72°C for 30 sec. Following
PCR reaction, the melting curve was constructed by in-
creasing the temperature from 72 to 95°C to ensure that
the correct product is amplified in the reaction. PCR was
repeated three times in doublets for each gene, and the
average Ct was used for further analysis. Gene-specific
primers for PPIA, GAPDHS and ACR were designed using
the advantages of Primer3 software and BLAST alignment
of Primer-BLAST service from NCBI [11]. Three best
primer pairs overlapping the intron sequence were or-
dered and after pretesting, the best of them was used
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pseudogenes for GAPDH gene in human genome [12],
neither of the three primer pairs ordered was suitable be-
cause of the dimer formations, and the primers used were
as in Barber et al. [13]. Primers for MND1 and SPATA22
were as in Okada et al. [4]. The PPIA (peptidylprolyl iso-
merase A (cyclophilin A)) gene was used as a reference
gene. Primer properties are summarized in Table 1.
Statistical analysis
Experimental data were analysed using STATISTICA 6.0.
and GraphPad Prism 5.04. The differences between the
control and experimental groups in the relative gene ex-
pression were analysed by KW ANOVA, and post hoc ana-
lysis was performed by Dunn‘s test. The p value that was
equal to or lower than 0.05 was considered to be significant
and was indicated with red asterisk in the column.
Results
A total of 47 testicular biopsies were analysed. As the
specimens were primarily used for sperm retrieval, in 13
cases the level or purity of isolated RNA was not suffi-
cient for further studies. In the remaining 34 samples,
morphological examination diagnosed nine biopsies as
Sertoli cell only (SCO, 26%), 12 as maturation arrest at
spermatocyte stage (MA), 12 as hypospermatogenesis
with few sperm cells present (HS) and one sample as ob-
structive azoospermia with normal spermatogenesis. A
commercial total testicular mRNA was used as a positive
control for the gene expression.
Table 2 summarizes individual characteristics of the
in vitro fertilization process, numbers of fertilized
oocytes, embryo transfers and the cycles as well as oc-
currence of clinical pregnancy. Fertilization rate for all
studied samples was 63%, in particular, for HS subset -
72% and MA subset – 54%. Pregnancy rate rate was
29% for whole set of patients, from this 32% for HS
group and 26% for MA group. For samples with posi-
tive expression of studied genes fertilization rate for
GAPDHS positive subset was 66%, ACR - 71%,
SPATA22 – 68%, MND1 – 70%, pregnancy rates were
8%, 6%, 18% and 36% respectively.Table 1 Primer sequences
Gene Accession no. Forward primer sequence






PPIA NM_021130.3 CCCACCGTGTTCTTCGACATTTesticular biopsy of OA showed a similar expression
pattern to that of commercial testicular RNA (Figure 1).
Three samples (10–12) from the HS group and six
from the MA group (17–24) showed no or low expres-
sion of the studied genes. In the SCO group, two samples
(25 and 26 in Table 2) showed decreased expression of
the tested genes, whereas in the remaining seven biopsies
only residual presence of GAPDHS, ACR and SPATA22
could be detected.
In patient 9 from the HS group and patients 22 and 23
from the MA group the expression of MND1 and
SPATA22 was detected and no ACR or GAPDHS gene
products were found.
Next, we looked whether any difference in relative ex-
pression of the studied genes could be found between
the histological groups of HS, MA and SCO. Relative
gene expression was significantly decreased for SPATA22
and GAPDHS in the SCO group (Figure 2). The ACR
gene was downregulated as well, but due to high inter-
individual differences and the low number of studied
samples in the groups the decrease was not significant.
Discussion
The main goal of all analytic procedures in patients with
non-obstructive azoospermia is to quickly obtain reliable
data for successful prediction of testicular sperm re-
trieval. Some laboratories attempted to predict sperm-
atogenesis with non-invasive techniques with differing
success [14-16]. To date, the only generally accepted
reliable predictor of successful TESE is testicular hist-
ology [17]. Analysis of the germ cell-specific gene ex-
pression in testicular samples can provide an additional,
supplementing approach to increase the prediction of
positive TESE outcome.
Testicular transcriptome consists of gene expression
patterns of both somatic and germ cells and has been in-
tensively studied in recent years [3]. The first studies
were focused on describing the global testicular gene ex-
pression and identifying testicular genes in mice [18]
and human [19]. Shima et al. [1] took advantage of the
first synchronous wave of spermatogenesis in pubertal
mice to locate the gene products to specific testicularReverse primer sequence






GCATCGAAGATGGACGAGTGGGT 92 this MS
ATTTTTGCCGACGAAGCAGTGAGC 230 this MS
CAGAGTTAAAAGCAGCCCTGGT 71 11
GGACCCGTATGCTTTAGGATGA 275 this MS
Table 2 Fertilization outcomes in individual patients
Sample Spermatogenesis Oocytes Fertilized Ebbryos transferred Number of cycles Clinical pregnancy
1 HS 4 4 2 1 No
2 HS 8 5 2 2 No
3 HS 9 8 3 1 Yes
4 HS 1 1 1 1 No
5 HS 5 3 1 1 No
6 HS 12 7 2 2 No
7 HS 5 2 1 1 No
8 HS 4 4 2 1 Yes(2)
9 HS 13 11 2 1 Yes(2)
10 HS 18 12 2 2 No
11 HS 3 3 2 1 Yes/AB
12 HS 10 6 2 1 Yes
HS total 92 66 22 15 7
13 MA 14 13 2 1 No
14 MA 8 5 4 2 No
15 MA 11 3 2 2 No
16 MA 9 5 2 1 No
17 MA 8 2 2 1 yes
18 MA 5 2 2 1 No
19 MA 8 4 4 3 yes
20 MA 5 5 2 1 Yes(2)
21 MA 5 4 NA NA No
22 MA 2 1 1 1 No
23 MA 9 4 1 1 Yes
24 MA 8 2 1 1 Yes/AB
MA total 92 50 23 15 6
25 SCO - - - - -
26 SCO - - - - -
27 SCO - - - - -
28 SCO - - - - -
29 SCO - - - - -
30 SCO - - - - -
31 SCO - - - - -
32 SCO - - - - -
33 SCO - - - - -
34 OA 4 2 2 1 No
HS – hypospermatogenesis; MA – maturation arrest; SCO – Sertoli cell only; OA – obstructive azoospermia; AB- miscarriage; N/A- data not available.
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for high-throughput analysis of cell-specific gene expres-
sion studies on animal models [20,21]. The data from
the above-mentioned studies provides a vast number of
possible gene candidates as markers of spermatogenesis
that fulfil the criteria of testis-specific gene expression,
are transcribed and translated at specific time points ofspermatogenesis, and their presence indicates correct
gamete development. In addition, it was shown recently
that besides changes in mRNA levels in azoospermic
men, the miRNA expression is also altered [22].
Another approach to TESE sample analysis is to verify
whether the expression of a single gene or a couple of








































































Figure 1 Heat map representing the differential gene expression
of the tested genes among individual samples and groups. Red
color indicates the highest gene expression (90th percentile), white
color indicates moderated gene expression and green color indicates
lowest gene expression (10% percentile). Other shades indicate
intermediate values.
Figure 2 The relative difference in the expression of tested genes
among control and experimental groups of hypospermatogenesis
(HS), maturation arrest (MA) and Sertoli cell- only syndrome (SCO).
Columns indicate the arithmetic mean of the relative expression of a
particular gene, whiskers indicate SEM. Control group (C) is indicated by
purple color and the relative expression was set as 100%. The
statistically significant differences between control and experimental
groups are indicated by red color of the column or red asterisk.
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infertility clinics. Detection of DAZ (deleted in azoo-
spermia), DAZL (DAZ-like) and protamine 2 (PRM2)
mRNA in testicular samples was shown to be an in-
formative tool for spermatogenesis evaluation [23].
Similar results were obtained with the BOULE mRNA
occurrence [24]. Ando et al. showed that expression ofVASA, ODF1, ODF2 (outer dense fiber 1 and 2) and
SMCP (sperm mitochondria-associated cysteine-rich
protein) genes was significantly stronger in the suc-
cessful TESE group [25]. Other genes expressed in
post-meiotic stage may also be good candidates for
the prediction of successful fertilization.
In our study, we followed expression of five genes that
are expressed at certain stages of the spermatogenesis
process and are important for meiosis and sperm devel-
opment. The MND1 and SPATA22 genes were selected
for spermatogenesis characterization in azoospermic pa-
tients because of the known significant gene expression
differences in different non-obstructive azoospermic pa-
tients [4]. The Mnd1/Gaj protein plays an important role
in homologous chromosome pairing and efficient cross-
over during meiosis [26]. The SPATA22 gene product
was shown to be involved in meiotic progression of
germ cells in mice [27]. The ACR mRNA appears first in
pachytene spermatocytes, reaching the maximum levels
in round spermatids, and preproacrosin protein appears
in spermatids [28]. The reason for non-obstructive azoo-
spermia in this case may be interrupted or incomplete
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loss of acrosin protease activity does not lead to inferti-
lity in mice and spermatozoa from knock-out mice can
penetrate zona pellucida of the oocyte [29]. The gene
encoding sperm-specific glyceradehyde-3-phosphate de-
hydrogenase, GAPDHS, was shown to be expressed
solely in haploid round and elongating spermatids
[30,31] to replace the function of somatic GAPDH gene,
whose expression ceases in germ cells. GAPDHS gene
expression may be a good marker for spermatogenesis
analysis, as its transcription and translation are tempor-
arily separated and mRNA forms a complex with an
RNA-binding protein, which results in translation and
mRNA degradation delay [32]. Therefore, expression of
the GAPDHS gene might be detectable even in poor-
quality or low-quantity testicular samples. Poor detec-
tion of gene expression in nine biopsies (10–12 from HS
and 17–24 from MA groups) suggests that in the tissue
analysed for RNA purification, spermatogenesis was ei-
ther greatly reduced or RNA was probably purified
mainly from somatic cells. An interesting pattern of gene
expression was observed in patients 9, 22 and 23 with
normal expression of MND1 and SPATA22 genes and
residual levels of GAPDHS and ACR genes. This might
indicate that spermatogenesis in these patients continues
undisturbed until meiosis, but either meiosis or spermio-
genesis is somehow impaired.
Fertilization and pregnancy rates in population of
studied patients were in accordance to those from pre-
vious studies. Fertilization rates for subsets of samples
with positive expression of studied genes showed uni-
form fertilization rates around 70%, only MND1 gene
was expressed in samples from SCO group where sperm
cells could not be retrieved. Surprisingly, for most prom-
ising markers of final steps of spermatogenesis, ACR and
GAPDHS, pregnancy rate was below 10%. This indicates
that expression analysis of present testicular genes can-
not indicate successful pregnancy in studied couples. It
is highly probable that in this process, oocyte and em-
bryo quality have higher impact on the successful preg-
nancy. Moreover, low number of studied samples does
not allow drawing any correlation between specific gene
expression and fertilization outcome.
All four studied genes are expressed at different stages
of spermatogenesis, and ACR, SPATA22 and GAPDHS
gene expression might be a good predictor of successful
TESE outcome. Nevertheless, analysis of a greater num-
ber of testicular biopsies is needed to confirm that
changes in gene expression of the selected genes can
serve as markers to justify repeated TESE. Another thing
to consider is that spermatogenesis is a dynamic process
and TESE sample analysis provides information about
the gene expression and spermatogenesis state at a sin-
gle time point only.A novel non-invasive approach to prediction of the
state of spermatogenesis and pathophysiology of testicu-
lar tissues via the detection of germ cell-specific mRNA
traces in seminal plasma was introduced recently [33,34].
Future analysis of germ cell-specific genes, including
those from our study, or GAPDH/GAPDHS ratio in cell-
free seminal plasma from azoospermic patients might be-
come a promising non-invasive tool for TESE success
prediction. The advantage of this technique is that the
seminal analysis provides complex whole-testis physi-
ology in comparison to the TESE sample representing a
limited region of the analysed tissue.
To sum up, non-obstructive azoospermia is a complex
pathophysiological state that leads to changes of gene
expression in the testes, and understanding this process
may lead to identification of the molecular markers of
the spermatogenesis level.
Conclusions
Expression analysis of genes whose expression occurs
exclusively in germ cells during spermatogenesis pro-
vides sensitive confirmation of the histological diagnosis
of SCO syndrome, as it was decreased in all histologi-
cally identified SCO patients. In the case of maturation
arrest or hypospermatogenesis, gene expression analysis
could help determine the stage at which spermatogenesis
arrest occurs and be a key factor in making the decision
whether repeated TESE could be considered after pre-
vious ICSI failure.
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